vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and SAUL CENTERS, INC. (BFS). Click either name above to swap in a different company.
Azenta, Inc. is the larger business by last-quarter revenue ($148.6M vs $75.1M, roughly 2.0× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -10.4%, a 19.0% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs 0.8%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
AZTA vs BFS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $75.1M |
| Net Profit | $-15.4M | $6.5M |
| Gross Margin | 42.9% | — |
| Operating Margin | -4.9% | 65.4% |
| Net Margin | -10.4% | 8.7% |
| Revenue YoY | 0.8% | 10.6% |
| Net Profit YoY | -15.7% | -19.6% |
| EPS (diluted) | $-0.34 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $75.1M | ||
| Q3 25 | $159.2M | $72.0M | ||
| Q2 25 | $143.9M | $70.8M | ||
| Q1 25 | $143.3M | $71.9M | ||
| Q4 24 | $147.4M | $67.9M | ||
| Q3 24 | $150.6M | $67.3M | ||
| Q2 24 | $144.3M | $66.9M | ||
| Q1 24 | $136.4M | $66.7M |
| Q4 25 | $-15.4M | $6.5M | ||
| Q3 25 | $50.9M | $10.5M | ||
| Q2 25 | $-48.0M | $10.7M | ||
| Q1 25 | $-47.7M | $9.8M | ||
| Q4 24 | $-11.0M | $8.1M | ||
| Q3 24 | $-6.6M | $14.5M | ||
| Q2 24 | $-6.6M | $14.4M | ||
| Q1 24 | $-137.4M | $13.6M |
| Q4 25 | 42.9% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 46.2% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 46.7% | — | ||
| Q3 24 | 45.5% | 73.6% | ||
| Q2 24 | 44.8% | 74.2% | ||
| Q1 24 | 43.8% | 72.8% |
| Q4 25 | -4.9% | 65.4% | ||
| Q3 25 | 1.2% | 69.1% | ||
| Q2 25 | -1.3% | 68.7% | ||
| Q1 25 | -12.7% | 66.5% | ||
| Q4 24 | -5.9% | 82.9% | ||
| Q3 24 | -3.1% | 72.8% | ||
| Q2 24 | -4.9% | 75.0% | ||
| Q1 24 | -18.1% | 72.4% |
| Q4 25 | -10.4% | 8.7% | ||
| Q3 25 | 32.0% | 14.6% | ||
| Q2 25 | -33.4% | 15.1% | ||
| Q1 25 | -33.3% | 13.6% | ||
| Q4 24 | -7.5% | 11.9% | ||
| Q3 24 | -4.4% | 21.5% | ||
| Q2 24 | -4.5% | 21.6% | ||
| Q1 24 | -100.8% | 20.4% |
| Q4 25 | $-0.34 | $0.15 | ||
| Q3 25 | $1.12 | $0.32 | ||
| Q2 25 | $-1.05 | $0.33 | ||
| Q1 25 | $-1.04 | $0.29 | ||
| Q4 24 | $-0.25 | $0.22 | ||
| Q3 24 | $-0.25 | $0.48 | ||
| Q2 24 | $-0.12 | $0.48 | ||
| Q1 24 | $-2.48 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $8.7M |
| Total DebtLower is stronger | — | $468.4M |
| Stockholders' EquityBook value | $1.7B | $307.8M |
| Total Assets | $2.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $8.7M | ||
| Q3 25 | $279.8M | $11.8M | ||
| Q2 25 | $270.0M | $5.3M | ||
| Q1 25 | $253.6M | $6.5M | ||
| Q4 24 | $377.5M | $10.3M | ||
| Q3 24 | $280.0M | $7.2M | ||
| Q2 24 | $336.5M | $6.9M | ||
| Q1 24 | $353.5M | $7.1M |
| Q4 25 | — | $468.4M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $455.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $1.7B | $307.8M | ||
| Q3 25 | $1.7B | $316.6M | ||
| Q2 25 | $1.7B | $322.4M | ||
| Q1 25 | $1.7B | $328.4M | ||
| Q4 24 | $1.7B | $335.8M | ||
| Q3 24 | $1.8B | $341.8M | ||
| Q2 24 | $2.0B | $345.7M | ||
| Q1 24 | $2.2B | $347.1M |
| Q4 25 | $2.1B | $2.2B | ||
| Q3 25 | $2.1B | $2.2B | ||
| Q2 25 | $2.0B | $2.1B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.3B | $2.1B | ||
| Q1 24 | $2.6B | $2.0B |
| Q4 25 | — | 1.52× | ||
| Q3 25 | — | 5.02× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | 4.70× | ||
| Q4 24 | — | 1.36× | ||
| Q3 24 | — | 4.37× | ||
| Q2 24 | — | 4.17× | ||
| Q1 24 | — | 4.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $99.8M |
| Free Cash FlowOCF − Capex | $14.7M | — |
| FCF MarginFCF / Revenue | 9.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | 15.35× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $99.8M | ||
| Q3 25 | $2.2M | $20.6M | ||
| Q2 25 | $25.8M | $26.6M | ||
| Q1 25 | $14.4M | $30.4M | ||
| Q4 24 | $29.8M | $121.2M | ||
| Q3 24 | $17.7M | $26.5M | ||
| Q2 24 | $9.8M | $32.1M | ||
| Q1 24 | $8.7M | $33.8M |
| Q4 25 | $14.7M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $8.3M | $-28.3M | ||
| Q2 24 | $1.3M | $-12.5M | ||
| Q1 24 | $428.0K | $-11.7M |
| Q4 25 | 9.9% | — | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 5.5% | -42.1% | ||
| Q2 24 | 0.9% | -18.7% | ||
| Q1 24 | 0.3% | -17.6% |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 6.2% | 81.5% | ||
| Q2 24 | 5.9% | 66.7% | ||
| Q1 24 | 6.1% | 68.3% |
| Q4 25 | — | 15.35× | ||
| Q3 25 | 0.04× | 1.97× | ||
| Q2 25 | — | 2.48× | ||
| Q1 25 | — | 3.10× | ||
| Q4 24 | — | 14.98× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | — | 2.22× | ||
| Q1 24 | — | 2.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
BFS
Segment breakdown not available.
